FibroBiologics宣布融资2500万美元

2024-12-23 21:54

FibroBiologics (NASDAQ:FBLG) on Monday said it has entered into a standby equity purchase agreement (SEPA) with YA II PN, an investment fund managed by Yorkville Advisors Global.
The agreement allows FibroBiologics to sell up to $25 million in the aggregate of its common stock to Yorkville over the course of two years.
Yorkville agreed to advance to FibroBiologics the first $15 million available under the agreement in three equal tranches to be evidenced by convertible promissory notes, the company said.
The first tranche in the amount of $5 million was funded upon entry into the SEPA. Subject to the satisfaction of certain conditions, the second tranche of $5 million will fund after the filing of a registration statement covering the resale of the shares issuable to Yorkville under the promissory notes, it added.
The third tranche of $5 million will fund following the effectiveness of the registration statement and receipt of shareholder approval in satisfaction of Nasdaq rules, FibroBiologics said.
FibroBiologics can sell an additional $10 million of its common stock to Yorkville, subject to Yorkville’s consent and other conditions, while the convertible promissory notes remain outstanding.
FBLG +6.22% premarket to $2.39.
Source: Press Release

More on FibroBiologics